Back to Search
Start Over
Open-Label Trial of Amikacin Liposome Inhalation Suspension in Mycobacterium abscessusLung Disease
- Source :
- Chest; October 2023, Vol. 164 Issue: 4 p846-859, 14p
- Publication Year :
- 2023
-
Abstract
- Mycobacterium abscessusis the second most common nontuberculous mycobacterium respiratory pathogen and shows in vitro resistance to nearly all oral antimicrobials. M abscessustreatment success is low in the presence of macrolide resistance.
Details
- Language :
- English
- ISSN :
- 00123692 and 19313543
- Volume :
- 164
- Issue :
- 4
- Database :
- Supplemental Index
- Journal :
- Chest
- Publication Type :
- Periodical
- Accession number :
- ejs63484417
- Full Text :
- https://doi.org/10.1016/j.chest.2023.05.036